Monday, February 10, 2025

Patients Seek Varied Remedies for Chemotherapy-Induced Nerve Damage

Similar articles

Chemotherapy-induced peripheral neuropathy (CIPN) poses significant challenges for cancer patients, often limiting treatment options and affecting quality of life. A recent survey conducted by the Multinational Association of Supportive Care in Cancer highlights the diverse approaches patients take to manage this debilitating side effect.

Table of Contents

Subscribe Weekly Market Access News

* indicates required

Prevalence of Preventive Measures

The survey revealed that a substantial majority of respondents, 71%, did not engage in any preventive strategies against CIPN. Among those who did, prescribed medications or supplements were the most favored options, chosen by 30% of participants. This indicates a reliance on medical guidance when available, yet a significant portion remains without preventive support.

Treatment Strategies Employed

When addressing CIPN, exercise emerged as the most common treatment method, utilized by 47% of patients. Additionally, 33% turned to prescription medications such as gabapentin, despite it not being guideline-recommended, while only 8% used duloxetine, which aligns with clinical guidelines. Notably, nearly half of the participants also resorted to non-prescribed medications, highlighting a gap in effective, evidence-based treatments.

Key inferences drawn from the survey include:

  • Patients often lack access to or awareness of guideline-recommended CIPN prevention strategies.
  • There is a significant reliance on self-prescribed and non-prescribed treatments, which may not be effective.
  • Exercise is a preferred non-pharmacological approach, suggesting its potential role in CIPN management.

The findings indicate that in the absence of robust, guideline-supported interventions, many cancer patients are compelled to explore alternative methods with uncertain efficacy. The reliance on non-prescription remedies and the internet underscores the need for better communication and resources from healthcare providers.

Enhancing patient education and expanding research into effective CIPN treatments are crucial steps forward. By establishing clear, evidence-based guidelines, healthcare professionals can better support patients in managing neuropathy, ultimately improving treatment adherence and quality of life for those undergoing chemotherapy.

Source


This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article